New Strategies but Modest Benefit in Uveal MelanomaNew Strategies but Modest Benefit in Uveal Melanoma

New therapies being tried in uveual melanoma include combination everolimus, pasireotide long-acting release, and the MEK inhibitor trametinib. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news